Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200

Yalcin A. D., Genc G. E., Celik B., GÜMÜŞLÜ S.

Asia Pacific Congress of Allergy, Asthma and Clinical Immunology, Taipei, Taiwan, 14 - 17 November 2013, vol.68, pp.20 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 68
  • City: Taipei
  • Country: Taiwan
  • Page Numbers: pp.20
  • Akdeniz University Affiliated: Yes